Jean Nordstrom of Sixera Pharma AB
joined us for World Orphan Drug Congress USA 2015 to present about '
Restoring Skin Barrier Function: New Treatment for Netherton Syndrome'
.
Download the presentation now to learn about:
-
Unmet medical need and market
-
In Vivo proof of principle
-
Project status and next steps
-
Opportunity
...and
much
more!
Get your copy here!
To find out more about how
Sixera Pharma AB's new treatment for Netherton Syndrome
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.